FACULTAD DE MEDICINA
Facultad
Duke University
Durham, Estados UnidosPublicaciones en colaboración con investigadores/as de Duke University (18)
2023
-
Brachial vessel injuries: High morbidity and low mortality injuries
Current Therapy of Trauma and Surgical Critical Care (Elsevier), pp. 564-571.e9
-
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials
Thrombosis Research, Vol. 230, pp. 27-32
-
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors
American Journal of Psychiatry
2022
-
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors
Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327
-
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial
The Lancet Haematology, Vol. 9, Núm. 8, pp. e594-e604
2021
-
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z)
Nature Communications
-
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Nature Communications, Vol. 12, Núm. 1
-
Reproducibility of adipogenic responses to metabolism disrupting chemicals in the 3T3-L1 pre-adipocyte model system: An interlaboratory study
Toxicology, Vol. 461
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
-
Cohort profile: Pregnancy and childhood epigenetics (PACE) consortium
International Journal of Epidemiology, Vol. 47, Núm. 1, pp. 22-23u
-
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523
2017
-
Transancestral mapping and genetic load in systemic lupus erythematosus
Nature Communications, Vol. 8
2016
-
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
Journal of the American Heart Association, Vol. 5, Núm. 9
2015
-
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014
Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 654-656
2013
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
New England Journal of Medicine, Vol. 369, Núm. 14, pp. 1317-1326
2005
-
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
Thrombosis and Haemostasis, Vol. 94, Núm. 4, pp. 750-759
2004
-
Compliance with recommended prophylaxis for venous thromboembolism: Improving the use and rate of uptake of clinical practice guidelines
Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 2, pp. 221-227